Aligos Therapeutics, Inc.

ALGS | NASDAQ | 0 Sledující

$9.16

1.33%

$0.12

Sledovat

Overview Metrics Financials

Breakdown	12/31/2024 USD	12/31/2023 USD	12/31/2022 USD	12/31/2021 USD
Total revenue	3,945 -74.60%	15,529 +11.66%	13,907 +219.04%	4,359 -
Cost of revenue	0 -100.00%	3,069 -16.49%	3,675 -96.47%	104,153 -
Gross profit	3,945 -68.34%	12,460 +21.77%	10,232 +110.25%	-99,794 -
Operating expense	93,099 -10.18%	103,656 -7.02%	111,487 -15.97%	132,680 -
Operating income	-89,154 -1.17%	-88,127 +9.69%	-97,580 +23.96%	-128,321 -
Pretax Income	-130,880 -50.64%	-86,884 +9.44%	-95,940 +25.16%	-128,189 -
Tax Provision	331 -58.36%	795 +650.00%	106 -25.87%	143 -
Net income	-131,211 -49.65%	-87,679 +8.71%	-96,046 +25.16%	-128,332 -
EPS	-20.94 -494.89%	-3.52 -56.44%	-2.25 +30.12%	-3.22 -
Diluted EPS	-20.94 -494.89%	-3.52 -56.44%	-2.25 +30.12%	-3.22 -
Average Shares	6,265 -74.81%	24,873 -41.74%	42,695 +7.13%	39,855 -
Diluted Average Shares	6,265 -74.81%	24,873 -41.74%	42,695 +7.13%	39,855 -
EBIT	-89,154 -1.17%	-88,127 +9.69%	-97,580 +23.96%	-128,321 -
EBITDA	-89,154 -4.82%	-85,058 +9.42%	-93,905 +24.60%	-124,543 -

Soubory cookie používáme ke zlepšení prohlížení na webu.